103 related articles for article (PubMed ID: 2654432)
1. The molecular biology of medullary thyroid carcinoma. A model for cancer development and progression.
Nelkin BD; de Bustros AC; Mabry M; Baylin SB
JAMA; 1989 Jun; 261(21):3130-5. PubMed ID: 2654432
[TBL] [Abstract][Full Text] [Related]
2. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
[TBL] [Abstract][Full Text] [Related]
3. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.
Mulligan LM; Gardner E; Smith BA; Mathew CG; Ponder BA
Genes Chromosomes Cancer; 1993 Mar; 6(3):166-77. PubMed ID: 7682102
[TBL] [Abstract][Full Text] [Related]
4. Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells.
Nakagawa T; Mabry M; de Bustros A; Ihle JN; Nelkin BD; Baylin SB
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5923-7. PubMed ID: 3112776
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma.
Pfragner R; Höfler H; Behmel A; Ingolic E; Walser V
Cancer Res; 1990 Jul; 50(13):4160-6. PubMed ID: 1972348
[TBL] [Abstract][Full Text] [Related]
6. Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell differentiation.
Carson EB; McMahon M; Baylin SB; Nelkin BD
Cancer Res; 1995 May; 55(10):2048-52. PubMed ID: 7743500
[TBL] [Abstract][Full Text] [Related]
7. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
McHenry CR; Oppenheim DS; Murphy T; Broughan T; Vogt D; Goldfarb WB
Surgery; 1992 Oct; 112(4):728-32; discussion 732-3. PubMed ID: 1411944
[TBL] [Abstract][Full Text] [Related]
8. Human medullary thyroid carcinoma in culture provides a model relating growth dynamics, endocrine cell differentiation, and tumor progression.
Berger CL; de Bustros A; Roos BA; Leong SS; Mendelsohn G; Gesell MS; Baylin SB
J Clin Endocrinol Metab; 1984 Aug; 59(2):338-43. PubMed ID: 6736207
[TBL] [Abstract][Full Text] [Related]
9. Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine.
Sobol H; Narod SA; Schuffenecker I; Amos C; Ezekowitz RA; Lenoir GM
Henry Ford Hosp Med J; 1989; 37(3-4):109-11. PubMed ID: 2576938
[TBL] [Abstract][Full Text] [Related]
10. Statistical analysis of histomorphological findings in medullary thyroid carcinoma: distinction between the different familial forms of the disease. G.E.T.C. Groupe d'Etude des Tumeurs a Calcitonine.
Franc B; Rosenberg-Bourgin M; Auvert B; Caillou B; Dutrieux-Berger N; Floquet J; Houcke-Lecomte M; Justrabo E; Labat-Moleur F; Le Bodic MF
Henry Ford Hosp Med J; 1992; 40(3-4):261-3. PubMed ID: 1362419
[TBL] [Abstract][Full Text] [Related]
11. Family members of patients with sporadic medullary thyroid carcinoma must be screened for hereditary disease.
Olson JE; Hughes J; Alpern HD
Surgery; 1992 Dec; 112(6):1074-8; discussion 1078-9. PubMed ID: 1455309
[TBL] [Abstract][Full Text] [Related]
12. [Medullary thyroid carcinoma and some of its particularities].
Sidibé el H
Sante; 2007; 17(1):51-5. PubMed ID: 17897902
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetics of multiple endocrine neoplasia syndromes. I. Two different, unique clonal chromosome changes in a medullary thyroid carcinoma and in a C-cell thyroid hyperplasia.
Scappaticci S; Arrigoni G; Capra E; Maraschio P; Fraccaro M
Cancer Genet Cytogenet; 1992 Mar; 59(1):51-3. PubMed ID: 1348208
[TBL] [Abstract][Full Text] [Related]
14. [Thyroid carcinoma].
Namba H; Izumi M
Gan To Kagaku Ryoho; 1991 Jan; 18(1):22-9. PubMed ID: 1987898
[TBL] [Abstract][Full Text] [Related]
15. Histopathology of C Cells and Medullary Thyroid Carcinoma.
Schmid KW
Recent Results Cancer Res; 2015; 204():41-60. PubMed ID: 26494383
[TBL] [Abstract][Full Text] [Related]
16. RAS proto-oncogene in medullary thyroid carcinoma.
Moura MM; Cavaco BM; Leite V
Endocr Relat Cancer; 2015 Oct; 22(5):R235-52. PubMed ID: 26285815
[TBL] [Abstract][Full Text] [Related]
17. An overview of molecular abnormalities leading to thyroid carcinogenesis: a 1993 perspective.
Gagel RF
Stem Cells; 1997; 15 Suppl 2():7-13. PubMed ID: 9368282
[TBL] [Abstract][Full Text] [Related]
18. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
19. Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma.
Grauer A; Raue F; Gagel RF
Endocrinol Metab Clin North Am; 1990 Sep; 19(3):613-35. PubMed ID: 1979773
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition.
Elisei R; Cosci B; Romei C; Agate L; Piampiani P; Miccoli P; Berti P; Basolo F; Ugolini C; Ciampi R; Nikiforov Y; Pinchera A
J Clin Endocrinol Metab; 2004 Nov; 89(11):5823-7. PubMed ID: 15531548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]